The Final Frontier of LOTF: Digitalizing In Vivo Research

In this talk, we will discuss the state of digitalisation in in vivo research, explain why this phase of drug discovery is called the “final frontier”, and will examine actual requests from pharmaceutical and biotech companies when tasked with bringing new software into their existing technology stack to meet modernisation initiatives.